نتایج جستجو برای: p vivax

تعداد نتایج: 1272557  

2016
Anupkumar R. Anvikar Naman Shah Akshay C. Dhariwal Gagan Singh Sonal Madan Mohan Pradhan Susanta K. Ghosh Neena Valecha

Historically, malaria in India was predominantly caused by Plasmodium vivax, accounting for 53% of the estimated cases. After the spread of drug-resistant Plasmodium falciparum in the 1990s, the prevalence of the two species remained equivalent at the national level for a decade. By 2014, the proportion of P. vivax has decreased to 34% nationally, but with high regional variation. In 2014, P. v...

2015
Leanne J. Robinson Rahel Wampfler Inoni Betuela Stephan Karl Michael T. White Connie S. N. Li Wai Suen Natalie E. Hofmann Benson Kinboro Andreea Waltmann Jessica Brewster Lina Lorry Nandao Tarongka Lornah Samol Mariabeth Silkey Quique Bassat Peter M. Siba Louis Schofield Ingrid Felger Ivo Mueller Lorenz von Seidlein

BACKGROUND The undetectable hypnozoite reservoir for relapsing Plasmodium vivax and P. ovale malarias presents a major challenge for malaria control and elimination in endemic countries. This study aims to directly determine the contribution of relapses to the burden of P. vivax and P. ovale infection, illness, and transmission in Papua New Guinean children. METHODS AND FINDINGS From 17 Augus...

2012
Florian Noulin Céline Borlon Peter van den Eede Luc Boel Catherine M. Verfaillie Umberto D’Alessandro Annette Erhart

The development of a system for the continuous culture of Plasmodium vivax in vitro would benefit from the use of reticulocytes derived from differentiated hematopoietic stem cells (HCS). At present, the need to use both fresh reticulocytes and fresh P. vivax isolates represents a major obstacle towards this goal, particularly for laboratories located in non-endemic countries. Here, we describe...

2016
Michael T. White Shunmay Yeung Edith Patouillard Richard Cibulskis

The continued success of efforts to reduce the global malaria burden will require sustained funding for interventions specifically targeting Plasmodium vivax The optimal use of limited financial resources necessitates cost and cost-effectiveness analyses of strategies for diagnosing and treating P. vivax and vector control tools. Herein, we review the existing published evidence on the costs an...

Journal: :Molecules 2013
Adrian Martin Pohlit Renata Braga Souza Lima Gina Frausin Luiz Francisco Rocha E Silva Stefanie Costa Pinto Lopes Carolina Borsoi Moraes Pedro Cravo Marcus Vinícius Guimarães Lacerda André Machado Siqueira Lucio H Freitas-Junior Fabio Trindade Maranhão Costa

Plasmodium falciparum and P. vivax malaria parasites are now resistant, or showing signs of resistance, to most drugs used in therapy. Novel chemical entities that exhibit new mechanisms of antiplasmodial action are needed. New antimalarials that block transmission of Plasmodium spp. from humans to Anopheles mosquito vectors are key to malaria eradication efforts. Although P. vivax causes a con...

2012
Paul C. F. Graf Salomon Durand Carlos Alvarez Antonio Carmen Montalvan Mariella Galves Montoya Michael D. Green Meddly L. Santolalla Carola Salas Carmen Lucas David J. Bacon David J. Fryauff

The widespread use of primaquine (PQ) and chloroquine (CQ), together, may be responsible for the relatively few, isolated cases of chloroquine-resistant P. vivax (CQRPV) that have been reported from South America. We report here a case of P. vivax from the Amazon Basin of Peru that recurred against normally therapeutic blood levels of CQ. Four out of 540 patients treated with combination CQ and...

2017
Xavier C Ding Maria Paz Ade J Kevin Baird Qin Cheng Jane Cunningham Mehul Dhorda Chris Drakeley Ingrid Felger Dionicia Gamboa Matthias Harbers Socrates Herrera Naomi Lucchi Alfredo Mayor Ivo Mueller Jetsumon Sattabongkot Arsène Ratsimbason Jack Richards Marcel Tanner Iveth J González

The global prevalence of malaria has decreased over the past fifteen years, but similar gains have not been realized against Plasmodium vivax because this species is less responsive to conventional malaria control interventions aimed principally at P. falciparum. Approximately half of all malaria cases outside of Africa are caused by P. vivax. This species places dormant forms in human liver th...

2014
Benyun Shi Jiming Liu Xiao-Nong Zhou Guo-Jing Yang

BACKGROUND The transmission networks of Plasmodium vivax characterize how the parasite transmits from one location to another, which are informative and insightful for public health policy makers to accurately predict the patterns of its geographical spread. However, such networks are not apparent from surveillance data because P. vivax transmission can be affected by many factors, such as the ...

2015
Pham Vinh Thanh Nguyen Van Hong Nguyen Van Van Melva Louisa Kevin Baird Nguyen Xuan Xa Koen Peeters Grietens Le Xuan Hung Tran Thanh Duong Anna Rosanas-Urgell Niko Speybroeck Umberto D'Alessandro Annette Erhart

Plasmodium vivax resistance to chloroquine (CQ) is currently reported in almost all countries where P. vivax is endemic. In Vietnam, despite a first report on P. vivax resistance to chloroquine published in the early 2000s, P. vivax was still considered sensitive to CQ. Between May 2009 and December 2011, a 2-year cohort study was conducted in central Vietnam to assess the recommended radical c...

Journal: :Antimicrobial agents and chemotherapy 2008
B Russell F Chalfein B Prasetyorini E Kenangalem K Piera R Suwanarusk A Brockman P Prayoga P Sugiarto Q Cheng E Tjitra N M Anstey R N Price

In Papua, Indonesia, the antimalarial susceptibility of Plasmodium vivax (n = 216) and P. falciparum (n = 277) was assessed using a modified schizont maturation assay for chloroquine, amodiaquine, artesunate, lumefantrine, mefloquine, and piperaquine. The most effective antimalarial against P. vivax and P. falciparum was artesunate, with geometric mean 50% inhibitory concentrations (IC50s) (95%...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید